Literature DB >> 36008465

Crosstalk between m6A regulators and mRNA during cancer progression.

Xiaodong Niu1, Yuan Yang1, Yanming Ren1, Shengtao Zhou2, Qing Mao3, Yuan Wang4.   

Abstract

m6A modification, the most abundant and widespread RNA modification, is present and involved in the occurrence and development of various cancers. To date, most studies have mainly focused on the roles of a single m6A regulator (writer/eraser/reader) in various cancers, but cumulative evidence shows that aberrant m6A regulators and m6A levels exert dual effects (promoting and/or inhibiting roles) in cancer progression. Recently, studies have investigated the direct interactions between different m6A regulators (writer/eraser and reader) and mRNAs in a variety of cancers. In this review, we summarize the functions of m6A regulators and their roles in various types of cancers. We further propose the possible crosstalk mechanisms (Writer-m6A-Reader-mRNA axis and Eraser-m6A-Reader-mRNA axis) between different m6A regulators and mRNAs during cancer progression. We also discuss the clinical potential of m6A regulator‑targeting strategies.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36008465     DOI: 10.1038/s41388-022-02441-4

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   8.756


  136 in total

1.  Localization of N6-methyladenosine in the Rous sarcoma virus genome.

Authors:  K Beemon; J Keith
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

Review 2.  Dynamic RNA Modifications in Gene Expression Regulation.

Authors:  Ian A Roundtree; Molly E Evans; Tao Pan; Chuan He
Journal:  Cell       Date:  2017-06-15       Impact factor: 41.582

3.  Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells.

Authors:  R Desrosiers; K Friderici; F Rottman
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

4.  Modified nucleosides and bizarre 5'-termini in mouse myeloma mRNA.

Authors:  J M Adams; S Cory
Journal:  Nature       Date:  1975-05-01       Impact factor: 49.962

Review 5.  m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer.

Authors:  Huilin Huang; Hengyou Weng; Jianjun Chen
Journal:  Cancer Cell       Date:  2020-03-16       Impact factor: 31.743

Review 6.  RNA modifications modulate gene expression during development.

Authors:  Michaela Frye; Bryan T Harada; Mikaela Behm; Chuan He
Journal:  Science       Date:  2018-09-28       Impact factor: 47.728

7.  N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO.

Authors:  Guifang Jia; Ye Fu; Xu Zhao; Qing Dai; Guanqun Zheng; Ying Yang; Chengqi Yi; Tomas Lindahl; Tao Pan; Yun-Gui Yang; Chuan He
Journal:  Nat Chem Biol       Date:  2011-10-16       Impact factor: 15.040

Review 8.  The m6A RNA methylation regulates oncogenic signaling pathways driving cell malignant transformation and carcinogenesis.

Authors:  Mohammad Burhan Uddin; Zhishan Wang; Chengfeng Yang
Journal:  Mol Cancer       Date:  2021-04-04       Impact factor: 27.401

Review 9.  The role of m6A modification in the biological functions and diseases.

Authors:  Xiulin Jiang; Baiyang Liu; Zhi Nie; Lincan Duan; Qiuxia Xiong; Zhixian Jin; Cuiping Yang; Yongbin Chen
Journal:  Signal Transduct Target Ther       Date:  2021-02-21

10.  Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq.

Authors:  Dan Dominissini; Sharon Moshitch-Moshkovitz; Schraga Schwartz; Mali Salmon-Divon; Lior Ungar; Sivan Osenberg; Karen Cesarkas; Jasmine Jacob-Hirsch; Ninette Amariglio; Martin Kupiec; Rotem Sorek; Gideon Rechavi
Journal:  Nature       Date:  2012-04-29       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.